Omeros Solutions for better healing. <sup>®</sup>
About OmerosPipelineInvestorsNews

Omeros is a Seattle-based commercial-stage biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system.








©2005-2017 Omeros Corporation, All rights reserved.     Privacy Policy     Terms of Use     Compliance